| pubmed-article:18308197 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18308197 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:18308197 | lifeskim:mentions | umls-concept:C0004153 | lld:lifeskim |
| pubmed-article:18308197 | lifeskim:mentions | umls-concept:C0003591 | lld:lifeskim |
| pubmed-article:18308197 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:18308197 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18308197 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
| pubmed-article:18308197 | lifeskim:mentions | umls-concept:C0920591 | lld:lifeskim |
| pubmed-article:18308197 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:18308197 | pubmed:dateCreated | 2008-2-29 | lld:pubmed |
| pubmed-article:18308197 | pubmed:abstractText | Apolipoprotein mimetic peptides have been shown to dramatically reduce atherosclerosis in animal models. Atherosclerosis is an example of an inflammatory disorder. Published studies of apolipoprotein mimetic peptides in models of inflammatory disorders other than atherosclerosis suggest that they may have efficacy in a wide range of inflammatory conditions. | lld:pubmed |
| pubmed-article:18308197 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18308197 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18308197 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18308197 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18308197 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18308197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18308197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18308197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18308197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18308197 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18308197 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:18308197 | pubmed:issn | 1050-1738 | lld:pubmed |
| pubmed-article:18308197 | pubmed:author | pubmed-author:Anantharamaia... | lld:pubmed |
| pubmed-article:18308197 | pubmed:author | pubmed-author:NavabMohamadM | lld:pubmed |
| pubmed-article:18308197 | pubmed:author | pubmed-author:FogelmanAlan... | lld:pubmed |
| pubmed-article:18308197 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18308197 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:18308197 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18308197 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18308197 | pubmed:pagination | 61-6 | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:meshHeading | pubmed-meshheading:18308197... | lld:pubmed |
| pubmed-article:18308197 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18308197 | pubmed:articleTitle | The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis. | lld:pubmed |
| pubmed-article:18308197 | pubmed:affiliation | Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA. mnavab@mednet.ucla.edu | lld:pubmed |
| pubmed-article:18308197 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18308197 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:18308197 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18308197 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18308197 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18308197 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18308197 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18308197 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18308197 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18308197 | lld:pubmed |
